BALYASNY ASSET MANAGEMENT L.P. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 208 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$67,055
-37.3%
21,355
-17.5%
0.00%
Q2 2022$107,000
+1.9%
25,900
+42.7%
0.00%
Q1 2022$105,000
-82.3%
18,147
-80.5%
0.00%
-100.0%
Q1 2020$592,000
+72.1%
92,994
+126.1%
0.01%
+250.0%
Q4 2019$344,000
+84.9%
41,131
+138.2%
0.00%
+100.0%
Q2 2019$186,000
-37.2%
17,264
-33.1%
0.00%
-50.0%
Q4 2018$296,000
+36.4%
25,806
+78.6%
0.00%
+100.0%
Q3 2017$217,000
-93.0%
14,451
-95.9%
0.00%
-92.3%
Q2 2017$3,095,000
+212.6%
351,700
+114.8%
0.01%
+116.7%
Q1 2016$990,000
-93.2%
163,697
-89.8%
0.01%
-94.1%
Q4 2015$14,653,000
+3260.8%
1,604,890
+1977.5%
0.10%
+3300.0%
Q3 2015$436,000
-96.1%
77,252
-89.6%
0.00%
-97.1%
Q4 2014$11,268,000
+480.5%
740,857
+311.6%
0.10%
+586.7%
Q3 2014$1,941,000
-61.2%
180,000
-34.9%
0.02%
-73.7%
Q1 2014$5,001,000
+80.5%
276,600
+38.7%
0.06%
+58.3%
Q4 2013$2,771,000199,4650.04%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders